weight loss tirzepatide Retatrutide vs (2026): Differences in Loss, Metabol – Revolution Health & Wellness Tirzepatide Injection for Weight Loss

Participants received once-weekly semaglutide (initiated at 0.25 mg and gradually escalated to 2.0 mg) for 12 weeks, along with lifestyle intervention

Gaborit B, et al

10.1038/npp.2014.175 [DOI] [PMC free article] [PubMed] [Google Scholar] Jensen, C

It belongs to the class of GLP-1 receptor agonists, which mimic the natural incretin hormone responsible for regulating blood sugar and appetite. This dual-action effect allows semaglutide to simultaneously improve glycaemic control and promote weight losstwo outcomes that are closely interconnected in metabolic health

What your patient can expect Account setup information sent to patients Your patient will receive setup instructions